Crossref
EE404 COST-EFFECTIVENESS OF PERITONEAL DIALYSIS VERSUS HEMODIALYSIS FOR END-STAGE RENAL DISEASE IN TURKEY
Value in Health · 2026-06 · 29 (6) · S139-S140
DOI: 10.1016/j.jval.2026.03.698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von AYSEN SENTURK und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
SENTURK, A., SENTURK, E., Dogan, V., & Çukadar, F. (2026). EE404 COST-EFFECTIVENESS OF PERITONEAL DIALYSIS VERSUS HEMODIALYSIS FOR END-STAGE RENAL DISEASE IN TURKEY. Value in Health, 29(6), S139-S140. https://doi.org/10.1016/j.jval.2026.03.698
Vancouver
SENTURK A, SENTURK E, Dogan V, Çukadar F. EE404 COST-EFFECTIVENESS OF PERITONEAL DIALYSIS VERSUS HEMODIALYSIS FOR END-STAGE RENAL DISEASE IN TURKEY. Value in Health. 2026;29(6):S139-S140. doi:10.1016/j.jval.2026.03.698
BibTeX
@article{SENTURK2026,
author = {SENTURK, AYSEN and SENTURK, Engin and Dogan, Volkan and Çukadar, Fuat},
title = {EE404 COST-EFFECTIVENESS OF PERITONEAL DIALYSIS VERSUS HEMODIALYSIS FOR END-STAGE RENAL DISEASE IN TURKEY},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S139--S140},
doi = {10.1016/j.jval.2026.03.698}
}
EUVIMED